【摘要】 目的：研究清开灵注射液治疗血管性痴呆。方法：采用清开灵注射液治疗５０ 例轻、中度血管性痴呆患者，并设对照组２５ 例。结果：治疗ＭＭＳＥ，ＨＤＳ，ＡＤＬ 积分值增加明显优于对照组（ Ｐ＜ ０ ．０１） ；临床显效率为２８ ％ ，有效率为５４ ％ ，对照组分别为１６ ％ 和４０％ ，疗效明显优于对照组（ Ｐ＜ ０ ．０５） 。结论：清开灵注射液治疗轻中度血管性痴呆疗效肯定，值得进一步研究，推广应用。更多还原

【Abstract】 Objective: To investigate clinical effect of Qingkailing Injective in treating vascular dementia. Methods: 50 cases of low grade or moderate vascular dementia patients were treated by Qingkailing injection in comparison with 25 patients in control group. Results:The results showed that the increase of MMSE、HDS and ADL integral titer was prior to that in control group ( P <0.05). The effectual rate and the total effective rate in treated group were 28% and 54% respectively, that in control group were 16% and 40% respectively, the treated group were better than the control group ( P <0.05). Conclusion:The Qingkailing injection has definite therapeutic effect for low grade or moderate vascular dementia, which has the value of in depth study and extend.更多还原